HSR26-243: Real-World Persistence With CDK4/6 Inhibitors in Early and Metastatic HR-Positive, HER2-Negative Breast Cancer

View at publisher Summarise with VIRAT
Authors: Guannan Gong, Britny R. Brown, Sameer Pandya, Michelle L. Caetano, Robert Duffy Legare, Salma Taghzout, Mariah Ramos, Jessica Liu, Annette Hood, Michael Zummo, Maryam B. Lustberg
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Fields of Study & Subjects

Advanced Breast Cancer Therapies Breast Cancer Treatment Studies PARP inhibition in cancer therapy

Publication details

Journal / source
Journal of the National Comprehensive Cancer Network
Volume
24
Issue
3.5
Publication date
27 March 2026
Language
EN